Psychedelic Drugs: Considerations for Clinical Investigations
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 23, 2023
June 26, 2023
c22c8005-efa9-4373-893d-cf27911562b6
Related Documents
Clinical Pharmacology Considerations for Peptide Drug Products
Guidance DocumentDecember 14, 2023Center for Drug Evaluation and Research
Migraine: Developing Drugs for Preventive Treatment
Guidance DocumentJune 1, 2023Center for Drug Evaluation and Research
Opioid Analgesic Drugs: Considerations for Benefit-Risk Assessment Framework Guidance for Industry
Guidance DocumentJune 20, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.